In recent years, pharma companies have spent considerable sums on introducing customer relationship management (CRM). However, our research into the …
The withdrawal of Elan from Europe has provided a new platform for the launch of a new niche player in …
The head of the FDA Mark McClellan is to quit his post in order to lead the reform of the …
Japan's third largest pharmaceutical company Yamanouchi is to buy its national rival Fujisawa in a deal worth around $7.7 billion.Rumours …
Erbitux, the colorectal cancer drug once blighted by one of the biggest ever regulatory scandals has been granted marketing approval …
UK drug delivery specialist Profile Therapeutics says it expects marketing approval for its new inhaled cystic fibrosis drug in eight …
Mercury Healthcare has been chosen as the preferred supplier to run five new NHS fast-track surgery centres.Routine general surgery will …
Probably one of the biggest problems the pharmaceutical industry has had to overcome over the years is the question of …
Aventis’ chances of sidestepping the hostile takeover bid from Sanofi-Synthelabo are looking increasingly less likely as the ‘alternative scenarios’ it …
The government has signalled that the profusion of targets introduced to measure NHS performance have done their job, and says …